Zurich, Switzerland – A new non-profit organization has been launched in Europe to promote collaboration in women’s health innovation. The Swiss-based association, FemmeHealth Alliance (FHA), aims to bring together leaders from various sectors including capital, corporate, clinical, and policy through virtual and in-person events, as well as a research and dialogue series.
According to Maryann Umoren Selfe, Founder and President of FHA, Europe has top-tier science in women’s health but the solutions often remain isolated. “FHA’s goal is to change that by providing a platform where capital, science, and policy can work together towards the same agenda,” she stated.
Emmanuelle Lecomte-Brisset, Legal Co-Founder of FHA, added that the organization’s mission is to accelerate progress in women’s health by promoting collaboration and translating scientific advancements into accessible solutions.
FHA will kick off with a virtual briefing, “The Business of Women’s Health 2025: Key Trends and Insights,” on October 23, 2025, from 18:00-19:00 CEST. The event is open to partners and non-members. Members will have access to webinars, a members-only library, and invitations to in-person gatherings. FHA also invites partners and supporters to join their coalition that aims to narrow the gender-health equity gap.
Industry leaders have already expressed their support for the launch. “FemmeHealth Alliance plays a crucial role in bridging the gap between innovators and investors. By providing a consistent platform for collaboration, it will accelerate the growth of credible women’s health solutions in Switzerland and Europe,” said Daniel Delfosse, Vice Director of Swiss Medtech.
FemmeHealth Alliance is an independent organization from the employers of its founders.
For media inquiries, please contact info@femmehealthalliance.org.
Disclaimer: The information shared in this article is not intended as investment advice or a solicitation.